A Survey of Medical Oncologist’s Opinions and Perceptions Regarding the Management of Dermatologic Toxicities among mCRC Patients Treated with Vectibix (20160258) First published 26/04/2017 Last updated 02/07/2024 EU PAS number:EUPAS18060 Study Finalised